162 related articles for article (PubMed ID: 1777895)
1. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis.
Salusky IB; Goodman WG
Child Nephrol Urol; 1991; 11(3):165-8. PubMed ID: 1777895
[TBL] [Abstract][Full Text] [Related]
2. Renal osteodystrophy in dialyzed children.
Salusky IB; Goodman WG
Miner Electrolyte Metab; 1991; 17(4):273-80. PubMed ID: 1813790
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.
Salusky IB; Coburn JW; Brill J; Foley J; Slatopolsky E; Fine RN; Goodman WG
Kidney Int; 1988 May; 33(5):975-82. PubMed ID: 3392886
[TBL] [Abstract][Full Text] [Related]
5. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
[TBL] [Abstract][Full Text] [Related]
6. Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy.
Goodman WG; Salusky IB
Contrib Nephrol; 1991; 90():189-95. PubMed ID: 1959345
[TBL] [Abstract][Full Text] [Related]
7. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F
Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132
[TBL] [Abstract][Full Text] [Related]
8. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
Fournier A; Aparicio M
Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056
[No Abstract] [Full Text] [Related]
9. Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
Wadhwa NK; Suh H; Howell N; Cabralda T; Sokunbi D; Solomon M
Adv Perit Dial; 1993; 9():260-3. PubMed ID: 8105939
[TBL] [Abstract][Full Text] [Related]
10. Features of renal osteodystrophy in pediatric patients receiving regular peritoneal dialysis.
Salusky IB; Brill J; Oppenheim W; Goodman WG
Semin Nephrol; 1989 Mar; 9(1):37-42. PubMed ID: 2740652
[No Abstract] [Full Text] [Related]
11. The renal bone diseases in children treated with dialysis.
Sanchez CP; Salusky IB
Adv Ren Replace Ther; 1996 Jan; 3(1):14-23. PubMed ID: 8620364
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings.
Duarte ME; Peixoto AL; Pacheco AS; Peixoto AV; Rodriguez RD; Lugon JR; Cruz EA
Sao Paulo Med J; 1998; 116(5):1790-7. PubMed ID: 10030103
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Chan HW; Tsang WK; Chan CM; Fung SK; So SO; Tang HL; Tong MK; Lee KC; Chan AY
Perit Dial Int; 1998; 18(2):177-82. PubMed ID: 9576366
[TBL] [Abstract][Full Text] [Related]
14. Renal osteodystrophy in CAPD.
Hutchison AJ; Freemont AJ; Lumb GA; Gokal R
Adv Perit Dial; 1991; 7():237-9. PubMed ID: 1680434
[TBL] [Abstract][Full Text] [Related]
15. Renal osteodystrophy in chronic renal failure.
Ho LT; Sprague SM
Semin Nephrol; 2002 Nov; 22(6):488-93. PubMed ID: 12430093
[TBL] [Abstract][Full Text] [Related]
16. Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
Mathias R; Salusky I; Harman W; Paredes A; Emans J; Segre G; Goodman W
J Am Soc Nephrol; 1993 Jun; 3(12):1938-46. PubMed ID: 8338926
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and treatment of renal osteodystrophy: present and future].
Fernández E; Craver L
Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423
[No Abstract] [Full Text] [Related]
18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for renal osteodystrophy: a multivariant analysis.
Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D
J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of long-term treatment with calcium carbonate as a phosphate binder.
Malberti F; Surian M; Poggio F; Minoia C; Salvadeo A
Am J Kidney Dis; 1988 Dec; 12(6):487-91. PubMed ID: 3143260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
